0002004065-24-000002.txt : 20240411 0002004065-24-000002.hdr.sgml : 20240411 20240411170252 ACCESSION NUMBER: 0002004065-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 EFFECTIVENESS DATE: 20240411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nucleus Radiopharma, Inc. CENTRAL INDEX KEY: 0002004065 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-510391 FILM NUMBER: 24839193 BUSINESS ADDRESS: STREET 1: 514 HIGH STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 9804833788 MAIL ADDRESS: STREET 1: 514 HIGH STREET CITY: PALO ALTO STATE: CA ZIP: 94301 D 1 primary_doc.xml X0708 D LIVE 0002004065 Nucleus Radiopharma, Inc. 514 HIGH STREET PALO ALTO CA CALIFORNIA 94301 9804833788 DELAWARE Nucleus Labs, Inc. None Corporation true 2022 Charles Conroy 514 High Street Palo Alto CA CALIFORNIA 94301 Executive Officer Director Justin Butler 514 High Street Palo Alto CA CALIFORNIA 94301 Director Manu Nair 514 High Street Palo Alto CA CALIFORNIA 94301 Director Mary Kate Wold 514 High Street Palo Alto CA CALIFORNIA 94301 Director Norman Sharpless 514 High Street Palo Alto CA CALIFORNIA 94301 Director Michael Rossi 514 High Street Palo Alto CA CALIFORNIA 94301 Director Chris McDonald 514 High Street Palo Alto CA CALIFORNIA 94301 Director Tyrell Rivers 514 High Street Palo Alto CA CALIFORNIA 94301 Director Other Health Care Decline to Disclose 06b false 2023-09-15 false true true Preferred Stock can convert to underlying shares of Common Stock. false 0 66099956 66099956 0 false 12 0 0 0 false Nucleus Radiopharma, Inc. /s/Charles Conroy Charles Conroy Chief Executive Officer 2024-04-11